Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
726 questions in 98 reviews · Pregnancy and Childbirth
current versionsNo studies 726 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Fatigue ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Persistent anaemia symptoms ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Thromboembolic events ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with oral iron vs oral iron (Comparison 10) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with oral iron vs oral iron (Comparison 10) Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with oral iron vs oral iron (Comparison 10) Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Maternal mortality ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Red blood cell transfusion vs non‐transfusion (Comparison 2) Maternal mortality ‐ not reported · patients with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs no screening Thyroid dysfunction diagnosed in pregnancy: hyperthyroid · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs no screening Pre‐eclampsia · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs no screening Preterm birth · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs no screening Miscarriage · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs no screening Adverse effects associated with the intervention · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs no screening Death (defined as all fetal and neonatal deaths) · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs case finding Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ < 85 at 3 years of age · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Universal screening vs case finding Adverse effects associated with the intervention · women during pregnancy Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving… (2015) · Cochrane | no estimate extracted | NR | No studies |
Fibre supplementation vs no intervention Primary outcome ‐ improvement in constipation ‐ not reported · Women being treated for constipation in pregnancy Interventions for treating constipation in pregnancy (2015) · Cochrane | no estimate extracted | NR | No studies |
Fibre supplementation vs no intervention Primary outcome ‐ consistency of stools ‐ not reported · Women being treated for constipation in pregnancy Interventions for treating constipation in pregnancy (2015) · Cochrane | no estimate extracted | NR | No studies |
Stimulant laxatives vs bulk‐forming laxatives Primary outcome ‐ pain on defecation ‐ not reported · women with treating constipation in pregnancy Interventions for treating constipation in pregnancy (2015) · Cochrane | no estimate extracted | NR | No studies |
Fibre supplementation vs no intervention Primary outcome ‐ pain on defecation ‐ not reported · Women being treated for constipation in pregnancy Interventions for treating constipation in pregnancy (2015) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic vs placebo Side effects of treatment · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections (2014) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic vs placebo Duration of admission to neonatal intensive care unit · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections (2014) · Cochrane | no estimate extracted | NR | No studies |
AFI vs SDVP: summary of findings table Perinatal deaths · pregnant women to prevent adverse pregnancy outcome Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse… (2008) · Cochrane | no estimate extracted | NR | No studies |